Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Baker Bros. Advisors LP reported a 6.70% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Baker Bros. Advisors LP reported a 6.70% stake in Monte Rosa Therapeutics, Inc., 4,345,736 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 4,345,736
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 6.70% | 4,345,736 |
| Baker Bros. Advisors (GP) LLC | 6.70% | 4,345,736 |
| Julian C. Baker | 6.70% | 4,345,736 |
| Felix J. Baker | 6.70% | 4,345,736 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Baker Bros. Advisors LP
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G/A · Baker Bros. Advisors LP · May 15, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026